Atara Biotherapeutics (ATRA) Return on Equity [ROE] (2014 - 2024)
Atara Biotherapeutics' Return on Equity [ROE] was -8768.28% in FY2024, down 8523.78 percentage points from -244.50% in FY2023.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Return on Equity [ROE] (2014 - 2024) Analysis & Trends
From FY2014 onward, Atara Biotherapeutics has reported Return on Equity [ROE] for 11 years.
- Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -8675.90 percentage points (FY2019 to FY2024).
- The FY2024 figure marks the lowest annual Return on Equity [ROE] in data going back to FY2014.
- Per Business Quant data, Return on Equity [ROE] in earlier years was -244.50% in FY2023 (-132.11 pp), -112.39% in FY2022 (-20.71 pp), -91.69% in FY2021 (-10.26 pp) and -81.43% in FY2020 (+10.95 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Atara Biotherapeutics | 124.14 Mn | 114.24 Mn | 959,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -50,254.60% |
| Dec 31, 2023 | -1,133.48% |
| Jun 30, 2023 | -836.46% |
| Mar 31, 2023 | -223.71% |
| Dec 31, 2022 | -146.61% |
| Sep 30, 2022 | -112.49% |
| Jun 30, 2022 | -103.92% |
| Mar 31, 2022 | -139.69% |
| Dec 31, 2021 | -115.58% |
| Sep 30, 2021 | -102.42% |
| Jun 30, 2021 | -87.20% |
| Mar 31, 2021 | -72.32% |
| Dec 31, 2020 | -75.11% |
| Sep 30, 2020 | -82.58% |
| Jun 30, 2020 | -94.87% |
| Mar 31, 2020 | -109.66% |
| Dec 31, 2019 | -95.34% |
| Sep 30, 2019 | -105.97% |
| Jun 30, 2019 | -107.82% |
| Mar 31, 2019 | -81.83% |
API Access
Atara Biotherapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();